Mirjam de With
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 8
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 1
- Pancreatic and Hepatic Oncology Research 1
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- Ron H.J. Mathijssen (13 shared papers)Ron H. N. van Schaik (9 shared papers)Sander Bins (8 shared papers)Esther Oomen‐de Hoop (7 shared papers)Maja Matić (3 shared papers)Dennis A. Hesselink (1 shared paper)Ruben A.G. van Eerden (1 shared paper)Marzia Del Re (1 shared paper)
- Journals
- Cancers (2 papers)Journal of Clinical Oncology (1 paper)ESMO Open (1 paper)Clinical Pharmacokinetics (1 paper)Annals of Oncology (1 paper)
- Partner nations
- NetherlandsItalyBelgium
In The Last Decade
Mirjam de With
13 papers receiving 196 citations
Peers
Comparison fields: 5 of 50
- Pharmacology 47
- Transplantation 9
- Oncology 72
- Gastroenterology 6
- Cancer Research 16
Countries citing papers authored by Mirjam de With
This map shows the geographic impact of Mirjam de With's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam de With with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam de With more than expected).
Fields of papers citing papers by Mirjam de With
This network shows the impact of papers produced by Mirjam de With. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam de With. The network helps show where Mirjam de With may publish in the future.
Co-authors
The 25 scholars most cited alongside Mirjam de With, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 49 | |
| 2 | 2023 | 40 | |
| 3 | 2021 | 31 | |
| 4 | 2018 | 18 | |
| 5 | 2023 | 14 | |
| 6 | 2022 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2023 | 8 | |
| 9 | 2020 | 6 | |
| 10 | 2022 | 4 | |
| 11 | 2019 | 3 | |
| 12 | 2021 | 2 | |
| 13 | 2018 | 1 |
About Mirjam de With
Mirjam de With is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology and Pharmacology, having authored 13 papers that have together received 199 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Cancer therapeutics and mechanisms (3 papers), Lung Cancer Treatments and Mutations (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Estrogen and related hormone effects (1 paper), Lung Cancer Research Studies (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Pharmacology (47 citations), Transplantation (9 citations), Oncology (72 citations), Gastroenterology (6 citations) and Cancer Research (16 citations). Mirjam de With has collaborated with scholars based in Netherlands, Italy and Belgium. Frequent co-authors include Ron H.J. Mathijssen, Ron H. N. van Schaik, Sander Bins, Esther Oomen‐de Hoop, Maja Matić, Dennis A. Hesselink, Ruben A.G. van Eerden, Marzia Del Re, Romano Danesi and Laure Elens. Their work appears in journals such as Cancers, Journal of Clinical Oncology, ESMO Open, Clinical Pharmacokinetics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.